Published in Gene Therapy Weekly, March 26th, 2009
"The two-hit trigger model postulates that dual target sites in the same transcript are often sufficient to initiate tasiRNA production,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.